Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Effects of alpha-lipoic Acid on body weight in obese subjects.

Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ, Lee IK, Lim S, Jang HC, Lee KH, Lee KU.

Am J Med. 2011 Jan;124(1):85.e1-8. doi: 10.1016/j.amjmed.2010.08.005.

PMID:
21187189
[PubMed - indexed for MEDLINE]
2.

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Schulz KF, Altman DG, Moher D; CONSORT Group.

Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.

PMID:
20335313
[PubMed - indexed for MEDLINE]
3.

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial.

Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, Kershen J, Rogers A, Simovic D, Schratzberger P, Kirchmair R, Losordo D.

Ann Neurol. 2009 Apr;65(4):386-93. doi: 10.1002/ana.21675.

PMID:
19399887
[PubMed - indexed for MEDLINE]
4.

Ranirestat for the management of diabetic sensorimotor polyneuropathy.

Bril V, Hirose T, Tomioka S, Buchanan R; Ranirestat Study Group.

Diabetes Care. 2009 Jul;32(7):1256-60. doi: 10.2337/dc08-2110. Epub 2009 Apr 14.

PMID:
19366965
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Glucose control and vascular complications in veterans with type 2 diabetes.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators.

N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1024-5. N Engl J Med. 2009 Sep 3;361(10):1028.

PMID:
19092145
[PubMed - indexed for MEDLINE]
Free Article
6.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

PMID:
18539916
[PubMed - indexed for MEDLINE]
Free Article
7.

Effect of a multifactorial intervention on mortality in type 2 diabetes.

Gaede P, Lund-Andersen H, Parving HH, Pedersen O.

N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.

PMID:
18256393
[PubMed - indexed for MEDLINE]
Free Article
8.

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group.

Diabetes Care. 2008 Mar;31(3):464-9. Epub 2007 Nov 26.

PMID:
18039804
[PubMed - indexed for MEDLINE]
9.

Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials.

Boulton AJ.

Diabetes Care. 2007 Oct;30(10):2752-3. No abstract available.

PMID:
17901534
[PubMed - indexed for MEDLINE]
10.

Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.

Tesfaye S, Tandan R, Bastyr EJ 3rd, Kles KA, Skljarevski V, Price KL; Ruboxistaurin Study Group.

Diabetes Care. 2007 Oct;30(10):2626-32. Epub 2007 Jul 10.

PMID:
17623822
[PubMed - indexed for MEDLINE]
11.

Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.

Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, Bastyr EJ 3rd, Litchy WJ, O'Brien PC.

Diabetes Care. 2007 Oct;30(10):2619-25. Epub 2007 May 18.

PMID:
17513707
[PubMed - indexed for MEDLINE]
12.

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R.

Diabetes Care. 2006 Nov;29(11):2365-70.

PMID:
17065669
[PubMed - indexed for MEDLINE]
13.

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Clin Ther. 2005 Aug;27(8):1164-80.

PMID:
16199243
[PubMed - indexed for MEDLINE]
14.

Diabetic neuropathies: a statement by the American Diabetes Association.

Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association.

Diabetes Care. 2005 Apr;28(4):956-62. Review. No abstract available.

PMID:
15793206
[PubMed - indexed for MEDLINE]
15.

Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study.

Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV.

Circulation. 2005 Jan 25;111(3):343-8. Epub 2005 Jan 17.

PMID:
15655130
[PubMed - indexed for MEDLINE]
Free Article
16.

Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy.

Ziegler D, Sohr CG, Nourooz-Zadeh J.

Diabetes Care. 2004 Sep;27(9):2178-83.

PMID:
15333481
[PubMed - indexed for MEDLINE]
17.

Postmarketing surveillance of adverse drug reactions: a correlational study approach using multiple data sources.

Rathmann W, Haastert B, Delling B, Gries FA, Giani G.

Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):51-7.

PMID:
15073746
[PubMed]
18.

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.

Ziegler D, Nowak H, Kempler P, Vargha P, Low PA.

Diabet Med. 2004 Feb;21(2):114-21.

PMID:
14984445
[PubMed - indexed for MEDLINE]
19.

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group.

Diabetes Care. 2003 Mar;26(3):770-6. Erratum in: Diabetes Care. 2003 Jul;26(7):2227.

PMID:
12610036
[PubMed - indexed for MEDLINE]
20.

Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities?

Ziegler D, Luft D.

Int Rev Neurobiol. 2002;50:431-63. Review.

PMID:
12198820
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk